Literature DB >> 16585313

Bilirubin measurement for neonates: comparison of 9 frequently used methods.

Karina Grohmann1, Markus Roser, Boris Rolinski, Ingrid Kadow, Cornelia Müller, Ada Goerlach-Graw, Matthias Nauck, Helmut Küster.   

Abstract

OBJECTIVE: High blood concentrations of bilirubin are toxic to the brain and may cause kernicterus. Therefore, determination of bilirubin levels is performed for many newborns, and several different methods are available. We compared 9 frequently used methods for bilirubin determination among newborns under routine conditions, to define their sequence of use.
METHODS: In a prospective study, bilirubin concentrations were determined with 9 different methods, ie, 3 skin test devices, 3 nonchemical photometric devices (including 2 blood gas analyzers), and 3 laboratory analyzers.
RESULTS: A total of 124 samples were obtained. All 3 laboratory methods showed very strong correlations with each other, and their means were used as comparison values. To these comparison values, the skin test devices had correlation coefficients between 0.961 and 0.966, and the nonchemical photometric devices between 0.980 and 0.994. Bland-Altman plots demonstrated good agreement with the comparison values for all nonchemical photometric devices. All skin test devices and 1 nonchemical photometric device underestimated bilirubin levels, particularly at high concentrations.
CONCLUSIONS: In the routine care of newborns, the first method for bilirubin testing should be a skin test. If the skin test result exceeds 200 micromol/L and other analytes are to be determined with a nonchemical photometric device, then bilirubin can be included in this analysis and the result trusted up to 250 micromol/L. If the skin test result exceeds 200 micromol/L and only bilirubin concentrations are needed, then a standard laboratory method is the first choice, to avoid repeated blood sampling. Bilirubin concentrations from nonchemical photometric devices that exceed 250 micromol/L should be confirmed with standard laboratory methods.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585313     DOI: 10.1542/peds.2005-0590

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late-preterm Chinese infants.

Authors:  Zhang-Bin Yu; Xiao-Yue Dong; Shu-Ping Han; Yu-Lin Chen; Yu-Fang Qiu; Li Sha; Qing Sun; Xi-Rong Guo
Journal:  Eur J Pediatr       Date:  2010-09-03       Impact factor: 3.183

2.  Transcutaneous bilirubin in predicting hyperbilirubinemia in term neonates.

Authors:  Y Ramesh Bhat; Amitha Rao
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

3.  Spatially confined quantification of bilirubin concentrations by spectroscopic visible-light optical coherence tomography.

Authors:  Colin Veenstra; Wilma Petersen; Ivo M Vellekoop; Wiendelt Steenbergen; Nienke Bosschaart
Journal:  Biomed Opt Express       Date:  2018-07-06       Impact factor: 3.732

4.  Reliability of transcutaneous bilirubin determination based on skin color determined by a neonatal skin color scale of our own.

Authors:  Silvia Maya-Enero; Júlia Candel-Pau; Jordi Garcia-Garcia; Xavier Duran-Jordà; María Ángeles López-Vílchez
Journal:  Eur J Pediatr       Date:  2021-01-06       Impact factor: 3.183

5.  Utility of Decision Rules for Transcutaneous Bilirubin Measurements.

Authors:  James A Taylor; Anthony E Burgos; Valerie Flaherman; Esther K Chung; Elizabeth A Simpson; Neera K Goyal; Isabelle Von Kohorn; Niramol Dhepyasuwan
Journal:  Pediatrics       Date:  2016-04-06       Impact factor: 7.124

6.  Risk factors for hyperbilirubinemia in breastfed term neonates.

Authors:  Ying-Juang Chen; Wei-Chuan Chen; Chung-Ming Chen
Journal:  Eur J Pediatr       Date:  2011-06-17       Impact factor: 3.183

7.  Cost savings with transcutaneous screening versus total serum bilirubin measurement for newborn jaundice in hospital and community settings: a cost-minimization analysis.

Authors:  Stephanie McClean; Krista Baerg; Julie Smith-Fehr; Michael Szafron
Journal:  CMAJ Open       Date:  2018-07-27

8.  Evaluation of a new transcutaneous bilirubinometer in Chinese newborns.

Authors:  H T Ho; T K Ng; K C Tsui; Y C Lo
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07-18       Impact factor: 5.747

9.  Discrepancies between transcutaneous and serum bilirubin measurements.

Authors:  James A Taylor; Anthony E Burgos; Valerie Flaherman; Esther K Chung; Elizabeth A Simpson; Neera K Goyal; Isabelle Von Kohorn; Nui Dhepyasuwan
Journal:  Pediatrics       Date:  2015-01-19       Impact factor: 7.124

10.  Comparison of a new transcutaneous bilirubinometer (Bilimed) with serum bilirubin measurements in preterm and full-term infants.

Authors:  Tanja Karen; Hans Ulrich Bucher; Jean-Claude Fauchère
Journal:  BMC Pediatr       Date:  2009-11-12       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.